EXHIBIT 4.30
THIS WARRANT HAS BEEN, AND THE SHARES OF COMMON STOCK WHICH MAY BE RECEIVED
PURSUANT TO THE EXERCISE OF THIS WARRANT WILL BE, ACQUIRED SOLELY FOR INVESTMENT
AND NOT WITH A VIEW TO, OR FOR RESALE IN CONNECTION WITH, ANY DISTRIBUTION
THEREOF. NEITHER THIS WARRANT NOR SUCH SHARES (TOGETHER, THE "SECURITIES") HAVE
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR ANY
STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE SOLD, OFFERED FOR SALE,
PLEDGED OR HYPOTHECATED IN THE ABSENCE OF SUCH REGISTRATION OR AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE COMPANY AND ITS COUNSEL THAT SUCH
DISPOSITION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS
OF THE ACT AND OF ANY APPLICABLE STATE SECURITIES LAWS.
NO. [SEE ATTACHED SCHEDULE] ISSUED [SEE ATTACHED SCHEDULE]
WARRANT TO PURCHASE COMMON STOCK
----------
THIS CERTIFIES THAT, for good and valuable consideration, [SEE ATTACHED
SCHEDULE FOR NAMES OF HOLDERS] (the "HOLDER") is entitled to subscribe for and
purchase from Adventrx Pharmaceuticals, Inc., a Delaware corporation (the
"COMPANY"), [SEE ATTACHED SCHEDULE FOR NUMBER OF SHARES] fully paid and
nonassessable shares of Common Stock, par value $0.001 per share ("COMMON
STOCK"), of the Company (as adjusted pursuant to Section 3 hereof) (the "WARRANT
SHARES") at a price per share equal to One Dollar and Twenty Five Cents ($1.25)
(as adjusted pursuant to Section 3 hereof) (the "EXERCISE PRICE"), subject to
the provisions and upon the terms and conditions hereinafter set forth.
1. METHOD OF EXERCISE; PAYMENT.
(A) Exercise Period. The purchase rights represented by this Warrant
may be exercised by the Holder during the term of this Warrant (as set
forth in Section 9 hereof) in whole or in part, at any time after the
Commencement Date, as defined below, by the surrender of this Warrant (with
the notice of exercise form attached hereto as Exhibit A (the "NOTICE OF
EXERCISE") duly executed) at the principal office of the Company.
(B) Cash Exercise. Upon exercise of this Warrant, the Holder shall pay
the Company an amount equal to the Exercise Price multiplied by the number
of Warrant Shares being purchased, by wire transfer or certified check
payable to the order of the Company. The person or persons in whose name(s)
any certificate(s) representing the Warrant Shares shall be issuable upon
exercise of this Warrant shall be deemed to have become the holder(s) of
record of, and shall be treated for all purposes as the record holder(s)
of, the Warrant Shares represented thereby (and such Warrant Shares shall
be deemed to have been issued) immediately prior to the close of business
on the date or dates upon which this Warrant is exercised.
1
(C) Stock Certificates. In the event of any exercise of the rights
represented by this Warrant, certificates for the Warrant Shares so
purchased shall be delivered to the Holder within a reasonable time after
exercise and, unless this Warrant has been fully exercised or has expired,
a new Warrant representing the shares with respect to which this Warrant
shall not have been exercised shall also be issued to the Holder within
such time.
2. STOCK FULLY PAID; RESERVATION OF SHARES. All of the Warrant Shares issuable
upon the exercise of the rights represented by this Warrant will, upon issuance
and receipt of the Exercise Price therefor, be fully paid and nonassessable, and
free from all preemptive rights, rights of first refusal or first offer, taxes,
liens and charges with respect to the issuance thereof. During the period within
which the rights represented by this Warrant may be exercised, the Company shall
at all times have authorized and reserved for issuance a sufficient number of
Warrant Shares to provide for the exercise of the rights represented by this
Warrant.
3. ADJUSTMENT OF EXERCISE PRICE AND NUMBER OF SHARES. The number and kind of
Warrant Shares purchasable upon the exercise of this Warrant and the Exercise
Price therefor shall be subject to adjustment from time to time upon the
occurrence of certain events, as follows:
(A) Reclassification, Consolidation or Reorganization. In case of any
reclassification of the Common Stock (other than a change in par value, or
as a result of a subdivision or combination), or in case of any
consolidation or merger of the Company with or into another corporation
(other than a Change of Control, as defined below) (any of which is a
"REORGANIZATION TRANSACTION"), the Company, or such successor corporation
as the case may be, shall execute a new warrant, providing that the holder
of this Warrant shall have the right to exercise such new warrant, and
procure upon such exercise and payment of the same aggregate Exercise
Price, in lieu of the Warrant Shares theretofore issuable upon exercise of
this Warrant, the kind and amount of shares of stock, other securities,
money and property as would be payable for the Warrant Shares issuable upon
exercise of this Warrant as if such Warrant Shares were outstanding on the
consummation of the Reorganization Transaction. For purposes of this
Warrant, the term "CHANGE OF CONTROL" shall mean (i) any acquisition of the
Company by means of merger, acquisition, or other form of corporate
reorganization in which outstanding shares of the Company are exchanged for
securities or other consideration issued, or caused to be issued, by the
acquiring corporation or its subsidiary or parent (other than a
reincorporation transaction or change of domicile) and pursuant to which
the holders of the outstanding voting securities of the Company immediately
prior to such consolidation, merger or other transaction fail to hold
equity securities representing a majority of the voting power of the
Company or surviving entity immediately following such consolidation,
merger or other transaction (excluding voting securities of the acquiring
corporation held by such holders prior to such transaction) or (ii) a sale
of all or substantially all of the assets of the Company.
(B) Stock Splits, Dividends and Combinations. In the event that the
Company shall at any time subdivide the outstanding shares of Common Stock,
or shall issue a stock dividend on its outstanding shares of Common Stock,
the number of Warrant Shares issuable upon exercise of this Warrant
immediately prior to such subdivision or to the issuance of such stock
dividend shall be proportionately increased, and the Exercise Price shall
be
2
proportionately decreased, and in the event that the Company shall at any
time combine the outstanding shares of Common Stock, the number of Warrant
Shares issuable upon exercise of this Warrant immediately prior to such
combination shall be proportionately decreased, and the Exercise Price
shall be proportionately increased, effective at the close of business on
the date of such subdivision, stock dividend or combination, as the case
may be.
4. TRANSFER OF WARRANT. This Warrant may only be transferred in compliance with
federal and state securities laws and, except as provided below, may not be
transferred except with the prior written consent of the Company, which shall
not be unreasonably withheld or delayed, and any purported transfer without such
prior written consent shall be null and void; provided, however, that the
Company may withhold its consent to transfer or assignment of this Warrant to
any person or entity who is deemed to be a competitor or prospective competitor
of the Company, such determination to be made in the reasonable judgment of the
Board.
5. CONDITION TO EXERCISE OF WARRANT. Each certificate evidencing the Warrant
Shares issued upon exercise of this Warrant shall be stamped or imprinted with a
legend substantially in the following form:
THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR
INVESTMENT AND NOT WITH A VIEW TO, OR FOR RESALE IN CONNECTION WITH, ANY
DISTRIBUTION THEREOF, AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT
OF 1933, AS AMENDED (THE "ACT"), OR ANY STATE SECURITIES LAWS. SUCH
SECURITIES MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN
THE ABSENCE OF SUCH REGISTRATION OR AN OPINION OF COUNSEL SATISFACTORY TO
THE COMPANY AND ITS COUNSEL THAT SUCH REGISTRATION IS NOT REQUIRED UNDER
THE ACT OR UNLESS SOLD PURSUANT TO RULE 144 OF SUCH ACT.
6. FRACTIONAL SHARES. No fractional Warrant Shares will be issued in connection
with any exercise hereunder, but in lieu of such fractional shares the Company
shall make a cash payment therefor upon the basis of the Exercise Price then in
effect.
7. REPRESENTATIONS AND WARRANTIES BY THE HOLDER. The Holder represents and
warrants to the Company as follows:
(A) This Warrant is being acquired for the Holder's own account, for
investment and not with a view to, or for resale in connection with, any
distribution or public offering thereof within the meaning of the
Securities Act of 1933, as amended (the "SECURITIES ACT"). Upon exercise of
this Warrant, the Holder shall, if so requested by the Company, confirm in
writing, in a form reasonably satisfactory to the Company, that the Warrant
Shares issuable upon exercise of this Warrant are being acquired for
investment and not with a view toward distribution or resale. The Holder is
an "accredited investor" within the meaning of the Securities Act.
(B) The Holder understands that this Warrant and the Warrant Shares
have not been registered under the Securities Act by reason of their
issuance in a transaction exempt from
3
the registration and prospectus delivery requirements of the Securities Act
pursuant to Section 4(2) thereof and that the Company's reliance upon such
exemption is predicated, in part, upon the Holder's representations and
warranties set forth in this Agreement. The Holder understands that this
Warrant and the Warrant Shares must be held by the Holder indefinitely, and
that the Holder must therefore bear the economic risk of such investment
indefinitely, unless a subsequent disposition thereof is registered under
the Securities Act or is exempted from such registration. The Holder
further understands that this Warrant and the Warrant Shares have not been
registered under the securities laws of any state.
(C) The Holder acknowledges that it is acquiring this Warrant without
being offered or furnished any offering literature or prospectus. The
Holder understands that neither the United States Securities and Exchange
Commission, nor any governmental agency charged with the administration of
the securities laws of any state nor any other governmental agency has
passed upon or reviewed the merits or qualifications of, or recommended or
approved the issuance of this Warrant or the Warrant Shares.
(D) The Holder understands that, except as provided in Section 10 of
this Warrant, the Company is under no obligation to register this Warrant
or the Warrant Shares.
(E) The Holder is a bona fide resident and domiciliary (not a
temporary or transient resident) of the state indicated in the signature
page hereto and the Holder has no present intention of becoming a resident
of any other state or jurisdiction.
(F) The Holder has such knowledge and experience in financial and
business matters that it is capable of evaluating the merits and risks of
the purchase of this Warrant and the Warrant Shares purchasable pursuant to
the terms of this Warrant and of protecting its interests in connection
therewith. The Holder is able to bear the economic risk of the purchase of
the Warrant Shares pursuant to the terms of this Warrant.
(G) The Holder of this Warrant agrees not to undertake any short
position with respect to the underlying common stock while this warrant
remains outstanding.
8. RIGHTS OF STOCKHOLDERS. No holder of this Warrant shall be entitled, as a
Warrant holder, to vote or receive dividends or be deemed the holder of Warrant
Shares or any other securities of the Company which may at any time be issuable
on the exercise hereof for any purpose, nor shall anything contained herein be
construed to confer upon the Holder any of the rights of a stockholder of the
Company or any right to vote for the election of directors or upon any matter
submitted to stockholders at any meeting thereof, or to give or withhold consent
to any corporate action (whether upon any recapitalization, issuance of stock,
reclassification of stock, change of par value, consolidation, merger,
conveyance, or otherwise) or to receive notice of meetings, or to receive
dividends or subscription rights or otherwise with respect to the Warrant Shares
until this Warrant shall have been exercised and the Warrant Shares purchasable
upon the exercise hereof shall have become deliverable, as provided herein.
4
9. TERM OF WARRANT.
(A) This Warrant shall become exercisable on the date of issuance set
forth below (the "COMMENCEMENT DATE") and shall no longer be exercisable as
of the earlier of (i) 5:00 p.m., San Diego, California local time, on the
date that is the three-year anniversary of the Commencement Date; (ii)
immediately prior to a Change of Control and (iii) 5:00 p.m., San Diego,
California local time, on the Call Termination Date (as defined below).
(B) Notwithstanding anything herein to the contrary, at any time after
the Commencement Date, if the closing price of one share of Common Stock
quoted in the over-the-counter market summary, the Bulletin Board Exchange,
the Nasdaq National Market or the closing price quoted on a national
securities exchange, whichever is applicable, is greater than 200% of the
Exercise Price for a period of 20 consecutive trading days, then thereafter
the Company shall have the right (the "COMPANY TERMINATION RIGHT"),
exercisable at the Company's sole discretion, to terminate this Warrant
with at least 10-days' prior written notice (the "TERMINATION NOTICE")
which Termination Notice shall state the date this Warrant shall terminate
(the "CALL TERMINATION DATE"); provided, however, that the Company may not
exercise the Company Termination Right unless a registration statement
registering the Warrant Stock has been declared effective and is effective
from the date of delivery of the Termination Notice until the Call
Termination Date, provided, further, that if this Warrant is terminated
pursuant to this Section 9(b), then the Company shall use commercially
reasonable efforts to maintain the effectiveness of a registration
statement registering the Warrant Stock until the date that is 15 days
after the Call Termination Date or, if earlier, the date the Holder shall
have sold all its Warrant Shares covered by such registration statement.
10. REGISTRATION RIGHTS.
(A) Piggy-back Rights. If (but without any obligation to do so) the
Company proposes to register any shares of Common Stock solely for cash
pursuant to a registration statement under the Securities Act, other than a
registration solely in connection with a transaction under Rule 145
promulgated under the Securities Act (a "PUBLIC OFFERING"), the Company
shall promptly give the Holder written notice of such Public Offering, at
least 10 business days prior to the filing of the registration statement
under the Securities Act regarding such Public Offering. Upon the written
request of the Holder given within 5 business days after delivery of such
written notice by the Company, the Company shall, subject to the provisions
of Section 10(b) below, use its best efforts to cause to be registered
under the Securities Act all of the Warrant Shares that the Holder has
requested to be registered.
(B) Underwriting. If the registration statement under which the
Company gives notice under this Section 10 is for an underwritten Public
Offering, the Company shall so advise the Holder. The right of the Holder
to registration pursuant to Section 10(a) above shall be conditioned upon
the Holder's participation in such underwriting and the inclusion of the
Warrant Shares in the underwriting to the extent provided herein. The
Holder shall (together with the Company and any other holders of Company
securities distributing their securities through such underwriting) enter
into an underwriting agreement in customary form with the underwriter or
underwriters selected for underwriting by the Company. Notwithstanding any
other provision of this Section 10, if the underwriter determines that
5
marketing factors require a limitation of the number of shares to be
underwritten, the underwriter may exclude some or all of the Warrant Shares
from such registration and underwriting.
(C) Furnish Information. It shall be a condition to the Company's
obligations to take any action under this Section 10 that the Holder shall
furnish to the Company such information regarding itself, the Warrant
Shares, and the intended method of disposition of such Warrant Shares as
shall be required to effect the registration of any Warrant Shares. In that
connection, the Holder shall be required to represent to the Company that
all such information which is given is both complete and accurate in all
material respects when made.
(D) Delay of Registration. The Holder shall have no right to obtain or
seek an injunction restraining or otherwise delaying any such registration
as the result of any controversy that might arise with respect to the
interpretation or implementation of this Section 10.
(E) Termination of Registration Rights. The Company shall have no
obligation to register Warrant Shares pursuant to this Section 10 with
respect to any request or requests made by any Holder on or after that date
which is one year after the date such Warrant Shares were deemed to be
acquired for purposes of determining the holding period of such Warrant
Shares under Rule 144 of the Act.
11. MISCELLANEOUS.
(A) This Warrant is being delivered in the state of California and
shall be construed and enforced in accordance with and governed by the laws
of the state of California, without giving effect to principles of
conflicts of laws.
(B) The headings in this Warrant are for purposes of reference only,
and shall not limit or otherwise affect any of the terms hereof.
(C) The terms of this Warrant shall be binding upon and shall inure to
the benefit of any successors or assigns of the Company and of the Holder
and of the Warrant Shares issued or issuable upon the exercise hereof.
(D) Any notice provided for or permitted under this Warrant shall be
treated as having been given (a) upon receipt, when delivered personally,
(b) upon receipt, when sent by confirmed facsimile or telecopy, (c) one day
after sending, when sent by commercial overnight courier with written
verification of receipt, or (d) three business days after deposit with the
United States Postal Service, when mailed postage prepaid by certified or
registered mail, return receipt requested, addressed (a) if to the Company,
at 9948 Hibert Street, Suite 100, San Diego, CA 92131, facsimile: (858)
271-9678, Attention: Nicholas J. Virca, or (b) if to the Holder, at such
address or facsimile number as the Holder shall have furnished to the
Company in writing, or at such other place of which the other party has
been notified in accordance with the provisions of this Section 11(d).
(E) This Warrant constitutes the full and entire understanding and
agreement between the parties with regard to the subjects hereof.
6
(F) Upon receipt of evidence reasonably satisfactory to the Company of
the loss, theft, destruction or mutilation of this Warrant and, in the case
of any such loss, theft or destruction, upon delivery of an indemnity
agreement reasonably satisfactory in form and amount to the Company or, in
the case of any such mutilation, upon surrender and cancellation of such
Warrant, the Company at the Holder's expense will execute and deliver to
the holder of record, in lieu thereof, a new Warrant of like date and
tenor.
(G) This Warrant and any provision hereof may be amended, waived or
terminated only by an instrument in writing signed by the Company and the
Holder.
(H) Receipt of this Warrant by the Holder shall constitute acceptance
of and agreement to the foregoing terms and conditions.
[Signature page follows.]
7
IN WITNESS WHEREOF, the Company has caused this Warrant to be signed by its
duly authorized officer.
Issued: [SEE ATTACHED SCHEDULE]
ADVENTRX PHARMACEUTICALS, INC.
By: /s/ Nicholas J. Virca
------------------------------------
Name: Nicholas J. Virca
Title: President and Chief Executive
Officer
[SEE ATTACHED SCHEDULE]
By:
------------------------------------
Name:
----------------------------------
Title:
---------------------------------
Address:
-------------------------------
-------------------------------
Facsimile:
-----------------------------
8
EXHIBIT A
NOTICE OF EXERCISE
TO: Adventrx Pharmaceuticals, Inc.
9948 Hibert Street, Suite 100
San Diego, CA 92131
The undersigned hereby elects to purchase ____________ shares of Common
Stock, par value $0.001 per share, of the Company ("COMMON STOCK") pursuant to
the terms of Section 1(b) of the Warrant to Purchase Common Stock dated
___________ 2003 (the "WARRANT"), and tenders herewith payment of the purchase
price of such shares in full.
Please issue a certificate or certificates representing said _________
shares of Common Stock in the name of the undersigned or in such other name as
is specified below:
Name:
----------------------------------
Address:
-------------------------------
-------------------------------
The undersigned hereby represents and warrants that the aforesaid shares of
Common Stock are being acquired for the account of the undersigned for
investment and not with a view to, or for resale, in connection with the
distribution thereof, and that the undersigned has no present intention of
distributing or reselling such shares, and that all representations and
warranties of the undersigned set forth in Section 7 of the Warrant are true and
correct as of the date hereof.
-----------------------------------------
By:
------------------------------------
Name:
----------------------------------
Title:
---------------------------------
Date:
----------------------------------
SCHEDULE OF WARRANTHOLDERS
ADVENTRX Pharmaceuticals, Inc. issued this form of Warrant to Purchase
Common Stock to each of the persons listed below on the dates set forth below
for the purchase of up to the number of shares of Common Stock listed opposite
such person's name below.
HOLDER WARRANT NO. ISSUE DATE SHARES
- --------------------------------------- ----------- ---------- ------
Charles and Leslie Close WC-210 10/15/2003 15,000
Elaine Dines WC-214 10/15/2003 15,000
Paul Mezei WC-236 10/15/2003 600
Steve Salovitch WC-245 10/15/2003 3,000
Schenk Family Trust/Carl Schenk Trustee WC-246 10/15/2003 7,500
Jay Silberman WC-251 10/15/2003 22,500
Andrew J. Maffey WC-256 10/15/2003 7,500
Richard Melnick WC-260 10/15/2003 16,000
Michael Kooper WC-227 10/15/2003 15,000